Every Form 4 that Jefferson Capital, Inc. (JCAP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow JCAP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JCAP filings page.
Jefferson Capital, Inc. (JCAP) reported an insider transaction by Chief Commercial Officer Penelope JoAnn Person246 shares of common stock in a sale classified as an open market or private transaction at $22.04 per share, and now holds 437,265 shares directly. The filing indicates the Rule 10b5-1 checkbox was not marked as being under a trading plan.
Jefferson Capital, Inc. (JCAP) reported that officer Mark Joseph Zellmann, President US Business Lines, disposed of Common Stock on August 17, 2026. He sold 56,000 shares in open-market or private transactions at a weighted average price of $23.7518 per share, with individual trade prices ranging from $23.54 to $24.17. On the same date, he also made a charitable gift of 6,250 shares of Common Stock to Fidelity Charitable. The filing indicates these transactions were not made pursuant to a Rule 10b5-1 trading plan.
Zellmann Mark Joseph reported acquisition or exercise transactions in this Form 4 filing.
Jefferson Capital executive Mark Joseph Zellmann, President US Business Lines, received two grants of stock options, each covering 12,500 shares of common stock. The Form 4 classifies these as compensation-related grants or awards rather than open-market purchases.
The reported transaction prices for the option grants are $20.13 and $34.13 per share, with both option series expiring on March 17, 2036. According to the footnote, the options vest in equal 1/5 installments each year, subject to Mr. Zellmann’s continued service through each vesting date.
OROS JOHN J reported acquisition or exercise transactions in this Form 4 filing.
Jefferson Capital director John J. Oros received two stock option grants as compensation. On March 11, 2026, he was awarded options covering 25,000 shares of common stock at $20.78 per share and another 25,000 shares at $34.78 per share, each expiring on March 10, 2036.
The filing shows 25,000 derivative shares reported as beneficially owned following each transaction entry, indicating these are new grants rather than sales. A footnote explains the options vest in three equal annual installments, subject to Mr. Oros continuing to serve through each vesting date.
Jefferson Capital, Inc. director and Chief Executive Officer and President David M. Burton reported a sale of common stock. On January 9, 2026, he sold 385,000 shares of Jefferson Capital common stock at $20.50 per share, coded as an open market or similar sale ("S").
According to the footnote, this represents the sale of shares to the underwriters in the issuer's secondary offering, rather than ordinary open-market trading. After this transaction, Burton beneficially owned 3,392,500 shares of Jefferson Capital common stock in direct form.
JCF IV JCAP Holding L.P. and affiliated JCF entities reported a large secondary sale of Jefferson Capital, Inc. (JCAP) common stock. On January 9, 2026, they sold 11,000,000 shares of common stock at a sale price of $19.6288 per share in a secondary offering that closed that day. Following this transaction, the filing reports that 32,721,808 shares of Jefferson Capital common stock were beneficially owned on an indirect basis.
The securities in this transaction are held directly by JCF IV JCAP Holding L.P., with a chain of general partners and controlling entities including JCF IV JCAP Holding GP LLC, JCF Associates IV L.P., JCF Associates IV Ltd., and J. Christopher Flowers. The reporting persons state that they disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest.